Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-20Clinical Trial Update: Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification [Phase 2]
Phase 2 clinical trial update for crenolanib in recurrent/refractory glioblastoma with PDGFRA amplification has completed.
-
CLINICAL_TRIALS trial_result · 2020-06-29Clinical Trial Update: Trial of AEO in New Glioblastoma (GBM) [Phase 2]
Phase 2 trial update for AEO in glioblastoma, currently with unknown status.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating a dendritic cell and glioma cell fusion vaccine with IL-12 for treatment-naïve glioblastoma/glioma pat…
-
CLINICAL_TRIALS trial_result · 2020-05-22Clinical Trial Update: Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas [Phase 2]
Phase 2 trial evaluating ABT-414 (pacritinib? actually ABT-414 is depatuxizumab mafodotin) alone or with temozolomide versus lomustine or te…
-
CLINICAL_TRIALS trial_result · 2020-05-22Clinical Trial Update: A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or Progression [Phase 2]
Phase 2 clinical trial of PX-866 in patients with glioblastoma at first relapse or progression has completed, with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-05-08Clinical Trial Update: Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma [Phase 3]
Phase 3 clinical trial evaluating angiotensin II receptor blockers, steroids, and radiotherapy in newly diagnosed glioblastoma has completed…
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma [Phase 3]
Phase 3 trial evaluating armodafinil for reducing cancer-related fatigue in patients with high-grade glioma has completed and results have b…
-
CLINICAL_TRIALS trial_result · 2020-04-30Clinical Trial Update: Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma [Phase 2]
Phase 2 trial evaluating ALECSAT as an add-on to standard care for glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy [NA]
Pilot study assessing PBR PET in brain tumor patients treated with chemoradiation or immunotherapy; completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-21Clinical Trial Update: MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma [NA]
Clinical trial evaluating MRI assessment of radiation and chemotherapy effects in newly diagnosed glioblastoma multiforme or anaplastic glio…
-
CLINICAL_TRIALS trial_result · 2020-04-10Clinical Trial Update: TH-302 in Combination With Bevacizumab for Glioblastoma [Phase 2]
Phase 2 trial evaluating TH-302 in combination with bevacizumab in glioblastoma has completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Nivolumab With DC Vaccines for Recurrent Brain Tumors [Phase 1]
Phase 1 trial evaluating nivolumab in combination with dendritic cell vaccines for recurrent brain tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma [Phase 2]
Phase 2 trial evaluating bevacizumab with or without radiation therapy in adults with recurrent glioblastoma has completed with results post…
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM) [Phase 2]
Phase 2 trial comparing standard-dose bevacizumab to low-dose bevacizumab plus lomustine in recurrent glioblastoma multiforme (GBM); study c…
-
CLINICAL_TRIALS trial_result · 2020-03-12Clinical Trial Update: Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas [Phase 2]
Phase 2 trial evaluating hypofractionated external radiotherapy with bevacizumab and temozolomide for recurrent gliomas; the study was termi…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma [Phase 2]
Phase 2 trial evaluating adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma.
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: ANG1005 in Patients With Recurrent High-Grade Glioma [Phase 2]
Phase 2 clinical trial update for ANG1005 in patients with recurrent high-grade glioma, including glioblastoma and other gliomas; status com…
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma [Phase 2]
Phase 2 clinical trial update of rindopepimut/GM-CSF in patients with relapsed EGFRvIII-positive glioblastoma has completed recruitment.
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma [Phase 2, Phase 3]
Clinical trial update for Toca 511 & Toca FC in recurrent high-grade glioma (Phase 2/3) has been terminated.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Repurposing Chlorpromazine in the Treatment of Glioblastoma [Phase 2]
Phase 2 clinical trial exploring repurposing of chlorpromazine for glioblastoma, including MGMT-unmethylated subtype.
-
CLINICAL_TRIALS trial_result · 2020-01-09Clinical Trial Update: A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma [Phase 2]
Phase 2 trial of PLX3397 in recurrent glioblastoma is terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 1]
Phase 1 trial update for a viral therapy in recurrent glioblastoma multiforme with related glioma conditions; results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors [Phase 1, Phase 2]
A dose-escalation and cohort-expansion study evaluating anti-CD27 (Varlilumab) with anti-PD-1 (Nivolumab) in advanced refractory solid tumor…
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: A Phase 2 Study of BGJ398 in Patients With Recurrent GBM [Phase 2]
A Phase 2 study of BGJ398 in patients with recurrent glioblastoma and related glioma subtypes has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma [Phase 2]
Phase 2 trial evaluating addition of Anlotinib Hydrochloride to the Stupp regimen versus Stupp regimen alone in newly diagnosed glioblastoma…